English | Español

Technology/Innovation
+ Technology/Innovation
Gene Johnson | Mar 25, 2017

Trials underway to determine the effectiveness of empagliflozin in treating heart failure
+ Community
Gene Johnson | Mar 25, 2017

CVS Health to launch a new prescription savings program
+ Regulatory
Gene Johnson | Mar 25, 2017

AstraZeneca receives complete response letter from FDA
+ Technology/Innovation
Erianne Leatherman | Mar 24, 2017

Arriva Medical considering appeal options following court's ruling
+ Regulatory
Gene Johnson | Mar 24, 2017

Pfizer's antibiotic drug Zavicefta available in Germany, United Kingdom
+ Regulatory
Gene Johnson | Mar 24, 2017

AstraZeneca, Circassia Pharmaceuticals partner to develop respiratory drugs
+ Community
Gene Johnson | Mar 24, 2017

Horizon Pharma launches initiative for people with rare genetic disease
+ Regulatory
Gene Johnson | Mar 24, 2017

China approves Xeljanz to treat moderate to severe rheumatoid arthritis

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes